首页 › 多发性骨髓瘤 › 艾奥瓦州 › Cedar Rapids
Cedar Rapids IA 多发性骨髓瘤临床试验
15项针对 多发性骨髓瘤的研究正在 Cedar Rapids及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
招募中3 期
- University of Iowa Hospitals and Clinics, Iowa City · 距离 25 英里
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
招募中1 期
- Research Site, Iowa City · 距离 25 英里
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
招募中3 期
- University of Iowa Hospital and Clinics, Iowa City · 距离 25 英里
Collection of Tissue Samples for Cancer Research
招募中观察性研究
- University of Iowa, Iowa City · 距离 25 英里
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中2 期
- University of Iowa, Iowa City · 距离 25 英里
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
招募中3 期
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
招募中1/2 期
- Research Site, Iowa City · 距离 25 英里
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
招募中3 期
- Research Site, Iowa City · 距离 25 英里
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
招募中2 期
- University of Iowa, Iowa City · 距离 25 英里
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
招募中3 期
- Physicians' Clinic of Iowa PC, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 距离 25 英里
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
招募中2 期
- University of Iowa, Iowa City · 距离 25 英里
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
招募中1 期
- University of Iowa Health Care, Iowa City · 距离 25 英里
Sleep Apnea in Patients With MGUS and MM
招募中观察性研究
- University of Iowa, Iowa City · 距离 25 英里
Activity Levels in Bone Marrow Transplant Patients
招募中观察性研究
- University of Iowa, Iowa City · 距离 25 英里
Limited-duration Teclistamab
招募中2 期
- University of Iowa Hospitals and Clinics, Iowa City · 距离 25 英里
其他城市的 多发性骨髓瘤试验
- New York City, NY60 项研究
- Boston, MA42 项研究
- Atlanta, GA41 项研究
- Houston, TX38 项研究
- Durham, NC37 项研究
- Nashville, TN32 项研究
- Denver, CO27 项研究
- Rochester, MN24 项研究
- St. Louis, MO24 项研究
- Columbus, OH24 项研究
- Baldwin Park, CA23 项研究
- Chicago, IL22 项研究
Cedar Rapids的其他研究
- 非小细胞肺癌20 项研究
- 乳腺癌17 项研究
- 急性髓系白血病16 项研究
- 癌症（所有类型）15 项研究
- 肺癌14 项研究
- 结直肠癌13 项研究
- 前列腺癌12 项研究
- 头颈鳞状细胞癌12 项研究
- 黑色素瘤10 项研究
- 卒中10 项研究
- 转移性癌症9 项研究
- 子宫内膜癌9 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。